Live Chat

Trade Novavax NVAX

Novavax live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2024 Nov 15, 12:47

Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) | Morningstar

Novavax Inc
Webhose 2024 Nov 14, 18:12

Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS

Novavax Inc
Webhose 2024 Nov 14, 13:17

What is HC Wainwright's Estimate for Novavax Q3 Earnings?

Novavax Inc
Webhose 2024 Nov 14, 00:00

Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data - November 14, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Nov 13, 22:57

Health Care Down as Vaccine Makers Slide — Health Care Roundup | Morningstar

Novavax Inc
Webhose 2024 Nov 13, 14:08

Novavax (NASDAQ:NVAX) Posts Earnings Results, Beats Expectations By $0.11 EPS

Novavax Inc
Webhose 2024 Nov 13, 13:55

Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript

Novavax Inc
Webhose 2024 Nov 13, 07:08

Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...

Novavax Inc
Webhose 2024 Nov 12, 14:04

Novavax's (NVAX) Buy Rating Reaffirmed at HC Wainwright

Novavax Inc
Webhose 2024 Nov 12, 12:33

Novavax Cuts FY24 Revenue View Below Market; Stock Drops In Pre-market - Update

Novavax Inc
Webhose 2024 Nov 12, 12:06

Novavax Inc. Q3 Loss Decreases, Beats Estimates

Novavax Inc
Webhose 2024 Nov 12, 05:21

Novavax earnings beat by $0.07, revenue topped estimates By Investing.com

Novavax Inc
Webhose 2024 Nov 12, 05:05

Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales By Reuters

Novavax Inc
Webhose 2024 Nov 12, 02:46

Novavax shares tumble 11% as revenue guidance disappoints By Investing.com

Novavax Inc
Webhose 2024 Nov 12, 00:00

Novavax's stock slides 7% as guidance cut offsets narrower-than-expected third-quarter loss | Morningstar

Novavax Inc
Webhose 2024 Nov 12, 00:00

NovaVax's stock slides 7% as lowered guidance offsets narrower-than-expected Q3 loss | Morningstar

Novavax Inc
Webhose 2024 Nov 11, 21:06

Continuation of Trump Trade takes Dollar to multi-month highs - Newsquawk US Market Wrap

Novavax Inc
Webhose 2024 Nov 11, 17:49

Novavax (NASDAQ:NVAX) Shares Gap Up - Should You Buy?

Novavax Inc
Webhose 2024 Nov 11, 15:34

Novavax Target of Unusually High Options Trading (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Nov 11, 15:03

Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold — Update | Morningstar

Novavax Inc
Webhose 2024 Nov 11, 14:05

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold | Morningstar

Novavax Inc
Webhose 2024 Nov 11, 14:02

FDA Lifts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine Candidate; Stock Up

Novavax Inc
Webhose 2024 Nov 11, 13:36

Novavax’s Clinical Hold on Covid, Flu Combo Trial Cleared by FDA

Novavax Inc
Webhose 2024 Nov 11, 13:30

U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial | Morningstar

Novavax Inc
Webhose 2024 Nov 11, 13:05

FDA Lifts Hold on Novavax's Combo COVID-Flu Shot

Novavax Inc
Webhose 2024 Nov 11, 05:57

Novavax stock soars as FDA removes clinical hold on its COVID and influenza shot By Investing.com

Novavax Inc
Webhose 2024 Nov 11, 00:00

Novavax to Report Q3 Earnings: Here's What to Expect - November 11, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Nov 11, 00:00

Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts? - November 11, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Nov 07, 08:52

Nisa Investment Advisors LLC Has $296,000 Position in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Nov 05, 20:42

Novavax (NVAX) Scheduled to Post Quarterly Earnings on Tuesday

Novavax Inc
Webhose 2024 Nov 05, 07:44

Vanguard Group Inc's Strategic Acquisition of Novavax Inc Shares

Novavax Inc
Webhose 2024 Nov 04, 21:30

Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024 | Morningstar

Novavax Inc
Webhose 2024 Nov 04, 07:05

Novavax, Inc. (NASDAQ:NVAX) Given Consensus Recommendation of “Hold” by Brokerages

Novavax Inc
Webhose 2024 Nov 04, 07:05

Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Rating of "Hold" from Analysts

Novavax Inc
Webhose 2024 Oct 30, 12:57

A Game-Changing Vaccine

Novavax Inc
Webhose 2024 Oct 29, 00:00

Novavax (NVAX) Stock Dips While Market Gains: Key Facts - October 29, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Oct 26, 12:10

Sanofi (NASDAQ:SNY) Q3 2024 Earnings Call Transcript

Novavax Inc
Webhose 2024 Oct 25, 13:12

Earnings call: Sanofi reports robust Q3 sales and raises 2024 EPS guidance By Investing.com

Novavax Inc
Webhose 2024 Oct 23, 00:00

Novavax (NVAX) Registers a Bigger Fall Than the Market: Important Facts to Note - October 23, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Oct 22, 18:09

Q&A on the 2024-2025 COVID-19 Vaccines

Novavax Inc
Webhose 2024 Oct 21, 00:00

Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? - October 21, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Oct 20, 20:00

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Novavax, Inc. and Encourages Investors to Contact the Firm | Morningstar

Novavax Inc
Webhose 2024 Oct 18, 08:34

Vontobel Holding Ltd. Acquires 261,464 Shares of Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Oct 18, 01:43

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX | Morningstar

Novavax Inc
Webhose 2024 Oct 17, 06:05

Brokerages Set Novavax, Inc. (NASDAQ:NVAX) Target Price at $18.33

Novavax Inc
Webhose 2024 Oct 17, 00:00

Novavax (NVAX) Advances While Market Declines: Some Information for Investors - October 17, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Oct 17, 00:00

Novavax Stock Falls After FDA Puts Two Vaccine Programs on Hold - October 17, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Oct 16, 23:54

3 Vaccine Stocks to Watch as Flu Season Approaches

Novavax Inc
Webhose 2024 Oct 16, 19:59

Novavax (NASDAQ:NVAX) Price Target Lowered to $25.00 at Jefferies Financial Group

Novavax Inc
Webhose 2024 Oct 16, 17:25

Novavax (NASDAQ:NVAX) Shares Gap Down - Time to Sell?

Novavax Inc
Webhose 2024 Oct 16, 16:08

BofA cuts Novavax target on clinical trial delay By Investing.com

Novavax Inc

Latest news

Global finance
Neil Wilson 2024 Nov 14, 17:00

Fed Hints at Tight Policy Amid Global Economic Uncertainty

Fed
Frances Wang 2024 Nov 14, 16:00

Dogecoin surges after Elon Musk issues crypto endorsement

Cryptocurrencies
Nvidia Blackwell AI Chips
Neil Wilson 2024 Nov 14, 16:00

Week ahead: Tech rally hinges on Nvidia earnings

Forex Indices
Frances Wang 2024 Nov 14, 16:00

Stock Market Today: Indexes Drop as Fed Rate Cuts are still underway

Fed Stocks
Frances Wang 2024 Nov 14, 16:00

What's Going On With Amazon Stock today? Is AMZN expected to rise?

Stocks AMZN
Dogecoin surges
Neil Wilson 2024 Nov 13, 17:00

Dogecoin surges as Trump unveils new government efficiency initiative with Musk andRamaswamy

Cryptocurrencies
Frances Wang 2024 Nov 13, 16:00

Japanese Yen to USD: Yen drops to fresh multi-month low against USD

Forex
Frances Wang 2024 Nov 13, 16:00

Asia markets today: Nikkei 225 up 0.18%, Hang Seng Index falls by 197 points

Indices

Info

Spread

0.05

Spread (%)

0.7062 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Friday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1156535552

Shares Outstanding

160094000

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-2.43

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments
Trustpilot
Live Chat